PFE vs RPAY · P/E 20, rev $15.03B vs rev $181.5M
Pfizer Inc (PFE) versus Repay Holdings Corp (RPAY) — a side-by-side from cached financials, not a winner call.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Repay Holdings Corp (RPAY) is a software - infrastructure company listed on NASDAQ.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Latest reported RPAY revenue for 2026-06-30 was $181.5M. Net income was -$20.9M. RPAY currently screens at market cap $292.4M.
PFE currently screens at market cap $147.73B and trailing P/E 19.8. RPAY currently screens at market cap $292.4M.
Not investment advice. Open the PFE and RPAY stock pages for the full models.
Not investment advice.